Factor VII activating protease polymorphism (G534E) is associated with increased risk for stroke and mortality

• Main Authors: Trompet, S, Pons, D, Kanse, S.M, De Craen, A.J.M, Ikram, M.A, Verschuren, J.J.W, Zwinderman, A.H, Doevendans, P.A.F.M, Tio, R.A, De Winter, R.J, Slagboom, P.E, Westendorp, R.G.J, Jukema, J.W
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: blood clotting factor 7; enzyme precursor; matrix metalloproteinase; placebo; pravastatin; proteinase; aged; article; controlled study; DNA polymorphism; female; genetic code; genetic polymorphism; genotype; hemostasis; human; human tissue; major clinical study; male; mortality; multicenter study; percutaneous coronary intervention; priority journal; randomized controlled trial; restenosis; risk assessment; stroke; vascular disease
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/183252
• Institution: National University of Singapore

10.4061/2011/424759